Leaflet MEDIKINET EM 5mg modified release capsules


Indicated for: attention deficit hyperactivity disorder (ADHD)

Route of administration: oral

Substance: methylphenidate (psychostimulant)

ATC: N06BA04 (Nervous system | Psychostimulants, agents used for adhd and nootropics | Centrally acting sympathomimetics)

Methylphenidate is a medication primarily used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. It works by increasing dopamine and norepinephrine levels in the brain, which helps improve focus and reduce impulsivity.

The medication is available in immediate-release or extended-release tablet forms, and the dosage is adjusted based on the individual needs of the patient. Treatment with methylphenidate should be monitored by a doctor, as it may have side effects such as insomnia, loss of appetite, headaches, or increased blood pressure.

Methylphenidate is contraindicated in individuals with certain conditions, such as glaucoma, severe anxiety disorders, or a history of substance abuse. It is also important for patients to inform their doctor about any other medications they are taking to avoid drug interactions.

This medication should be used with caution in children, adolescents, and adults, and pregnant or breastfeeding women should consult their doctor before starting treatment.

General data about MEDIKINET EM 5mg

  • Substance: methylphenidate
  • Date of last drug list: 01-10-2014
  • Commercial code: W56466001
  • Concentration: 5mg
  • Pharmaceutical form: modified release capsules
  • Quantity: 28
  • Product type: generic
  • Prescription restrictions: TAB2 - Medicines that are issued with a special prescription (narcotics) in yellow color.

Concentrations available for methylphenidate

  • 10mg
  • 18mg
  • 20mg
  • 27mg
  • 30mg
  • 36mg
  • 40mg
  • 54mg
  • 5mg